Amazon (NASDAQ: AMZN) stock has been hit especially hard in the latest market sell-off. Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned ...

Vertex said it is working with experienced hospitals throughout England to establish a network of treatment centres that can deliver Casgevy. Sun Pharma has agreed to acquire Checkpoint ...

BOSTON, February 18, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Stuart Arbuckle ...

Vertex reports Q4 earnings Monday, with Wall Street expecting $4.03 EPS and $2.78 billion revenue. Strong technicals support VRTX stock, but selling pressure and pipeline execution remain key ...

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...